Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Other Non-Current Assets (2014 - 2026)

Ocugen's (OCGN) quarterly Other Non-Current Assets came in at $318000.0 in Q1 2026, up 2.91% YoY from $309000.0 in Q1 2025, and up 0.63% on a QoQ basis from $316000.0 in Q4 2025.

Analysis

Ocugen (OCGN) Other Non-Current Assets (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Other Non-Current Assets data on file, last reported at $318000.0 in Q1 2026.

  • Quarterly Other Non-Current Assets rose 2.91% year-over-year to $318000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $318000.0 (up 2.91% YoY) and the FY2025 annual result came in at $316000.0, up 2.93% from the prior year.
  • Other Non-Current Assets rose to $318000.0 in Q1 2026, from $316000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $5.0 million in Q2 2025 to a low of $151000.0 in Q1 2022.
  • A 5-year average of $1.9 million and a median of $316000.0 in 2025 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 2791.39% — and 2024, when it sank 92.84%.
  • Tracing OCGN's Other Non-Current Assets over 5 years: stood at $4.1 million in 2022, then climbed by 4.87% to $4.3 million in 2023, then slumped by 92.84% to $307000.0 in 2024, then gained by 2.93% to $316000.0 in 2025, then climbed by 0.63% to $318000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $318000.0 (Q1 2026), $316000.0 (Q4 2025), and $314000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Ocugen 458.91 Mn 358.81 Mn - 3.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.82 Mn
Mar 31, 2026 4.21 Mn
Dec 31, 2025 4.47 Mn
Sep 30, 2025 4.70 Mn
Jun 30, 2025 312,000.00
Mar 31, 2025 309,000.00
Dec 31, 2024 3.90 Mn
Sep 30, 2024 305,000.00
Jun 30, 2024 302,000.00
Dec 31, 2023 4.29 Mn
Mar 31, 2023 3.95 Mn
Dec 31, 2022 4.09 Mn
Sep 30, 2022 4.23 Mn
Jun 30, 2022 4.37 Mn
Mar 31, 2022 1.63 Mn
Dec 31, 2021 1.80 Mn
Sep 30, 2021 151,000.00
Jun 30, 2021 151,000.00
Mar 31, 2021 151,000.00
Dec 31, 2020 714,000.00